172 related articles for article (PubMed ID: 34975498)
1. Design, Synthesis and Anti-Lung Cancer Evaluation of 1, 2, 3-Triazole Tethered Dihydroartemisinin-Isatin Hybrids.
Hou H; Qu B; Su C; Hou G; Gao F
Front Pharmacol; 2021; 12():801580. PubMed ID: 34975498
[TBL] [Abstract][Full Text] [Related]
2. Three-Carbon Linked Dihydroartemisinin-Isatin Hybrids: Design, Synthesis and Their Antiproliferative Anticancer Activity.
Dong M; Zheng G; Gao F; Li M; Zhong C
Front Pharmacol; 2022; 13():834317. PubMed ID: 35153798
[TBL] [Abstract][Full Text] [Related]
3. Artemisinin-isatin hybrids tethered via ethylene linker and their anti-lung cancer activity.
Wang R; Zhang Q; Chen M
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200563. PubMed ID: 36572639
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3).
Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV
Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and anti-breast cancer properties of butyric ester tethered dihydroartemisinin-isatin hybrids.
Zhao S; Zhang X; Tang M; Liu X; Deng J; Zhou W; Xu Z
Med Chem Res; 2023; 32(4):705-712. PubMed ID: 36816432
[TBL] [Abstract][Full Text] [Related]
7. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
Zhang YZ; Liu HL; He QS; Xu Z
Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and in vitro cytotoxicity evaluation of novel dihydroartemisinin-isatin hybrids tethered via different length of esters as potential anti-breast cancer agents.
Xu Z; Pan B; Chen L; Xu D
Fitoterapia; 2023 Apr; 166():105436. PubMed ID: 36693438
[TBL] [Abstract][Full Text] [Related]
9. Novel ester tethered dihydroartemisinin-3-(oxime/thiosemicarbazide)isatin hybrids as potential anti-breast cancer agents: Synthesis, in vitro cytotoxicity and structure-activity relationship.
Liu S; Wang S; Xu D; Pan B; Chen L; Zhao S; Xu Z; Zhou W
Drug Dev Res; 2023 Sep; 84(6):1175-1182. PubMed ID: 37165798
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin-Isatin Hybrids as Potent Anti-Breast Cancer Agents.
Xu Z; Zhang X; Liu J; Zhao S; Liu J; Zhou W
Chem Biodivers; 2023 Mar; 20(3):e202201257. PubMed ID: 36808231
[TBL] [Abstract][Full Text] [Related]
11. Two-carbon tethered artemisinin-isatin hybrids: design, synthesis, anti-breast cancer potential, and
Wang R; Huang R; Yuan Y; Wang Z; Shen K
Front Mol Biosci; 2023; 10():1293763. PubMed ID: 37928644
[TBL] [Abstract][Full Text] [Related]
12. The anti-breast cancer potential of dihydroartemisinin-isatin hybrids with hydrogen bond donors at C-3 position of isatin moiety.
Ding F; Chen X; Cao W; Dong T; Wang P
Fitoterapia; 2023 Mar; 165():105426. PubMed ID: 36608710
[TBL] [Abstract][Full Text] [Related]
13. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities.
Yan X; Lv Z; Wen J; Zhao S; Xu Z
Eur J Med Chem; 2018 Jan; 143():899-904. PubMed ID: 29227930
[TBL] [Abstract][Full Text] [Related]
15. Azide-Alkyne Cycloaddition En Route to 1
Singh A; Saha ST; Perumal S; Kaur M; Kumar V
ACS Omega; 2018 Jan; 3(1):1263-1268. PubMed ID: 30023800
[TBL] [Abstract][Full Text] [Related]
16. Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.
Tiwari MK; Coghi P; Agrawal P; Yadav DK; Yang LJ; Congling Q; Sahal D; Wai Wong VK; Chaudhary S
Eur J Med Chem; 2021 Nov; 224():113685. PubMed ID: 34303874
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of ciprofloxacin - 1,2,3-triazole hybrids as antitumor, antibacterial, and antioxidant agents.
Al-Taweel S; Al-Saraireh Y; Al-Trawneh S; Alshahateet S; Al-Tarawneh R; Ayed N; Alkhojah M; Al-Khaboori W; Zereini W; Al-Qaralleh O
Heliyon; 2023 Dec; 9(12):e22592. PubMed ID: 38125538
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of rhein-piperazine-furanone hybrids as potential anticancer agents.
He Y; Zhang SS; Wei MX
RSC Med Chem; 2024 Mar; 15(3):848-855. PubMed ID: 38516604
[TBL] [Abstract][Full Text] [Related]
19. Triazole linked mono carbonyl curcumin-isatin bifunctional hybrids as novel anti tubulin agents: Design, synthesis, biological evaluation and molecular modeling studies.
Sharma S; Gupta MK; Saxena AK; Bedi PM
Bioorg Med Chem; 2015 Nov; 23(22):7165-80. PubMed ID: 26515041
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of novel artemisinin-isatin hybrids with potential anti-leukemic cytotoxicity.
Wang P; Zhang Z; Cao W; Zhang X
Front Oncol; 2023; 13():1112369. PubMed ID: 37124527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
